Shares of Pfizer (PFE) are rising slightly in early trading on Thursday after announcing it will be moving forward with a once-daily weight-loss pill. Anjalee Khemlani reports more on the drug's early trials and how it may fit into the booming weight-loss drug market.

For more expert insight and the latest market action, click here to watch this full episode of Catalysts.

This post was written by Melanie Riehl